LEO Innovation Lab invests $5.5 million in healthtech

Ronny Kerr · March 10, 2017 · Short URL: https://vator.tv/n/4919

Healthtech in the U.S. far exceeds advancements made in Europe, according to the CEO of LEO iLAB

Editor's note: Our Splash Health, Wellness and Wearables event is coming up on March 23 in San Francisco. We'll have Mario Schlosser (Founder & CEO of Oscar Health), Brian Singerman (Partner, Founders Fund), Steve Jurvetson (Draper Fisher Jurvetson), J. Craig Venter (Human Longevity), Lynne Chou (Partner, Kleiner Perkins), Michael Dixon (Sequoia Capital), Patrick Chung (Xfund), Check out the full lineup and register for tickets before they jump! If you want to invest as little as $2500 in our startup winners, join the Vator Investment Club (VIC).


LEO Innovation Lab, the innovation arm of LEO Pharma, this week announced a $5.5 million investment in five startups serving the healthtech sector. Specifically, the firm backs startups that help people achieve healthy skin:

  • Combinostics (Finland), provider of data-driven solutions to improve clinical diagnosis.
  • Pacifica (San Francisco), provider of Android, iOS, and web tools for alleviating stress and anxiety. Currently boasts 1.25 million registered users.
  • Remedly (San Francisco), provider of cloud-based software for dermatologists, plastic surgeons, and med spas.
  • SkinVision (Holland), developer of an app that can analyze and track changes in moles and other skin conditions by using the smartphone's camera.
  • TalkLife (UK), an app and social network for young individuals to share personal struggles, give tips and encouragement, and more.

In this interview, we hear about the new investments from LEO iLab CEO Kristian Hart-Hansen, and we get his perspective on the difference between healthtech in U.S. versus Europe. Take a listen:

Support VatorNews by Donating

Read more from our "The Ronny Kerr Show" series

More episodes